Showing results (11-20 of 281) with videos related to
Sort By:
Pageof 29
European Journal of Pain (London, England)|February 5, 2008
Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose studyRalf Baron, Ulrike Brunnmüller, Matthias Brasser, et al.European Journal of Pain (London, England)|September 25, 2007
Modulation of sensitized C-fibers by adrenergic stimulation in human neuropathic painJörn Schattschneider, Marco Scarano, Andreas Binder, et al.Journal of Neurology|March 22, 2005
Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skinGunnar Wasner, Anne Kleinert, Andreas Binder, et al.The Journal of Pain|April 5, 2011
Topical high-concentration (40%) menthol-somatosensory profile of a human surrogate pain modelAndreas Binder, Maike Stengel, Oliver Klebe, et al.Journal of Neurology|September 10, 2005
No adrenergic sensitization of afferent neurons in painful sensory polyneuropathyJörn Schattschneider, Jens Uphoff, Andreas Binder, et al.Journal of Neurology|August 19, 2004
Idiopathic restless legs syndrome: abnormalities in central somatosensory processingJörn Schattschneider, Andre Bode, Gunnar Wasner, et al.Pain Reports|February 26, 2019
Sensitized vasoactive C-nociceptors: key fibers in peripheral neuropathic painJulia Forstenpointner, Dennis Naleschinski, Gunnar Wasner, et al.Pain Reports|February 2, 2019
Dynamic of the somatosensory system in postherpetic neuralgiaJanne Gierthmühlen, Olga Braig, Stefanie Rehm, et al.Current Medical Research and Opinion|June 2, 2009
Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathyRalf Baron, Victor Mayoral, Göran Leijon, et al.Clinical Drug Investigation|March 24, 2009
Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trialRalf Baron, Victor Mayoral, Göran Leijon, et al.Pageof 29